Introduction {#sec0005}
============

Endemic heroin use is associated with significant public health and social problems ([@bib0210]): in particular, high rates of mortality ([@bib0065]; [@bib0165]) and acquisitive offending ([@bib0030]; [@bib0180]). In the UK, structured addiction treatment is commissioned with the aim of reducing users' dependence on illicit drugs and minimizing the harms associated with these drugs, including premature death and offending ([@bib0090]). The front-line intervention offered for heroin dependence is opioid substitution therapy (OST) with methadone or buprenorphine ([@bib0145]). Psychological support is also available but recommended only as an adjunct to OST ([@bib0145]). In the UK, the treatment pathway for patients with heroin dependence is determined during a triage appointment with a drugs key-worker ([@bib0145]).

In medical and social research, randomised controlled trials (RCT's) are considered optimal for assessing the effectiveness of an intervention ([@bib0050]). However, RCTs and meta-analysis of interventions provided for heroin users have been underpowered to detect changes in mortality or offending and usually focus on intermediate outcomes such as reduced illicit opioid use and treatment retention ([@bib0015]; [@bib0005]; [@bib0010]; [@bib0115]; [@bib0120]). For example, a recent meta-analysis of RCTs for OST offered for heroin-using offenders was unable to detect an effect on future arrests (1 study, 62 subjects, RR: 0.60, 95% CI: 0.32--1.14) or incarceration (3 studies, 472 subjects, RR: 0.77, 95% CI: 0.36--1.64) ([@bib0160]).

Cohorts identified from routinely collected data can provide the necessary power to investigate rarer outcomes ([@bib0040]). Many studies of addiction treatment aim to quantify the effect of being treated by contrasting periods in and out of treatment. However, this will be a biased comparison if there are non-random reasons for why patients leave treatment which are related to the outcome under consideration. To account for this confounding bias, confounding variables should be measured over follow-up; however, such information is rarely available or incomplete. This problem can be avoided by analysing subjects according to initial treatment status --- something closer to the intention to treat principle routinely used in randomised controlled trials. Treatment and control subjects can then be balanced prior to follow-up, using propensity score methods.

This study used a large, observational, record-linkage dataset from England, to analyse the effect of initiating drug-treatment on subsequent offending and mortality. We focus on the effect of initiating treatment, ignoring the fact that many who begin treatment may drop-out early. Therefore, our study aims to quantify the impact of a policy where everybody with heroin dependence attends a triage appointment. The study is designed to best emulate what would have occurred during an RCT --- an approach that has been recommended in pioneering work from other areas of clinical research ([@bib0060]; [@bib0075], [@bib0205]).

We use this design to investigate two hypotheses: for heroin users identified in the criminal justice system, does initiating contact with treatment services reduce the risk of: (a) a future drug-related poisoning death and (b) a recorded acquisitive offence.

Methods {#sec0010}
=======

A cohort of heroin users was identified from probation (offender management) assessments, using inclusion and exclusion criteria. Following an eligible probation assessment, if subjects were recorded in treatment data as attending a triage appointment within two weeks they were classed as an *initiator*; otherwise they were classed as a *non-initiator*. Outcome events were defined as a drug-related poisoning (DRP) death or a day when the subject committed a recorded acquisitive offence over a maximum of one-year. Time-to-outcome was compared between initiators and non-initiators, irrespective of future treatment status. Balance between initiators and non-initiators was sought by matching on propensity scores calculated using an extensive set of baseline covariates available from probation assessment and historical offending records.

Datasets {#sec0015}
--------

Data were extracted from the Drug Data Warehouse --- a collection of case-linked national datasets on substance users in England, covering the period 1st April 2005 to 31st March 2009 ([@bib0130]).

The analysis cohort was identified from probation assessments recorded on the Offender Assessment System (OASys) database. OASys contains information from a structured interview between offender and probation officer with the aim of assessing an offender's recidivism risk and to identify particular needs ([@bib0140]). This assessment can form part of a pre-sentence report, to aid the judge's sentencing decision, or can be used to help probation services manage offenders post-sentence, for example after release from prison on licence (i.e. serving the remainder of a sentence in the community, under regular supervision by probation services).

Treatment data were obtained from the National Drug Treatment Monitoring System (NDTMS). NDTMS collects data on contact between substance-use disorder patients and structured treatment delivered by National Health Service and third-sector providers, which together account for almost all such provision in England. When a substance-use disorder patient initially contacts treatment services they undergo a triage appointment with a key-worker. The aim of this appointment is to assess the patient's needs and determine the most appropriate treatment. After this appointment, clients may be offered treatment within the assessing treatment agency, or onward referral to another service.

Details of sanctioned offending were determined through Police National Computer (PNC) records, for all offences that occurred since the age of ten, and resulted in a conviction, caution, warning or reprimand. A death occurring over follow-up was established from national mortality records.

Linkage was done based on a minimal identifier (initials, date of birth and gender). Additionally, criminal-justice system databases included an individually unique CJS identifier. Due to data release requirements, instances where more than one CJS identifier linked to a single minimal identifier were removed because this provided evidence that multiple subjects shared the latter details. This affected 33.6% of assessments in OASys and these were dropped from the analysis. Identifiers were fully anonymised prior to their release to the study team.

Inclusion/exclusion criteria {#sec0020}
----------------------------

Probation records were included in the analysis cohort provided the interviewed subject: was assessed between April 1 2005 and March 1 2009; reported weekly or more frequent use of heroin (by any route of administration); was aged 18--64 years. After resulted in 117,044 assessments (see [Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Flow-chart of selection of probation assessments into the analysis cohort.Fig. 1

A priori criteria were established so that, in turn, probation records were excluded from the study if:(i)The assessment was for a pre-sentence report which was associated with a subsequent prison sentence (n = 22,097)(ii)The assessment was post-sentence but carried out in prison (n = 15,169)(iii)The subject was already in treatment at the time of their probation assessment (n = 51,930)(iv)The subject had left treatment in the four weeks prior to their probation assessment (n = 3188)(v)The subject was already in the study at the time of assessment via a previous assessment (n = 9844)

The rationale for these exclusion criteria were: (i and ii) time incarcerated will be associated with lower DRPs, due to restricted access to drugs, and (naturally) offending risk and our data did not include date of prison release; (iii) the focus of the analysis is on the effect of initiating treatment, not on the effect of having been in treatment for some time; (iv) the four weeks following treatment cessation are known to confer elevated overdose risk ([@bib0170]) and so this cut-off was chosen as a wash-out period, prior to subsequent treatment; (v) was to ensure that no person could be entered into the analysis if they were already under observation.

Exposure definition {#sec0025}
-------------------

We designated a two-week *classification phase* that followed an eligible probation assessment. During this period, if the subject attended a triage appointment for opioid misuse treatment, as recorded in NDTMS data, they were classified as an *initiator* and the remainder who did not have any treatment contact were defined as a *non-initiator*. This two week cut-off was chosen by members of the research team, prior to analysis, as it was considered that a shorter period missed too many initiators, and a longer period would mean that the variables collected at the assessment would no longer be relevant.

Fourteen deaths occurred during the classification phase and these were excluded from analysis. Follow-up began after this period and ended on the earliest date of: the outcome under consideration, the end of data collection (31st March 2009), death from any cause, or one year after baseline assessment. The resulting analysis dataset consisted of 14,802 assessments (13,204 individuals).

Outcome definitions {#sec0030}
-------------------

An acquisitive-offence event was defined using the offence date, recorded in the PNC, for sanctioned offences with an offence code identifying the crime categories: theft, fraud and forgery, burglary, robbery, drug supply (including intent to supply) and prostitution. The PNC does not differentiate between drug-supply for material gain and 'social supply', whereby drugs are shared between individuals. Inclusion of drug-supply in the definition of 'acquisitive offences' is intended to increase its sensitivity, at the cost of some specificity. A fatal drug-related poisoning (DRP) was defined according to the UK harmonised definition ([@bib0155]) using the ICD-10 code ([@bib0215]) for the underlying cause of death.

Propensity scores {#sec0035}
-----------------

Propensity scores give the probability of a subject being an *initiator*, conditional on a set of baseline covariates. If the model used to predict propensity scores is correctly specified, then the covariates will be evenly distributed between subjects with the same propensity score. It follows that if all possible confounders are used to predict the propensity score -- that is all factors are identified which can influence both self-classification and outcome -- then the contrast between initiator and non-initiators with the same propensity score will be unconfounded ([@bib0190]).

Propensity scores were calculated using a logistic regression model which included variables available in the OASys system or calculated from historical PNC records. For ease of presentation, these covariates were grouped into eight types: demographic; relating to the assessment; relating to the current offence; drug use; alcohol use; employment and housing; mental and physical wellbeing; and offending history. All identified covariates were used to calculate the propensity scores. A description of each covariate is available in Appendix A in Supplementary material.

Propensity score matching and assessing balance {#sec0040}
-----------------------------------------------

Once propensity scores were calculated, the variable matching approach recommended in [@bib0185] was adopted, with up to *five non-initiators* selected for each *initiator.* The matching algorithm is described in detail in Appendix B in Supplementary material. The calliper distance was set as 20% of the standard deviation of the logit of the propensity scores ([@bib0020]).

Balance for each covariate, both prior to and post matching, was assessed using its standardised distance between *initiator* and *non-initiators*. This was calculated for each *initiator* assessment's worst match (i.e. the match with the greatest propensity score distance) to get a conservative measure of balance. The resulting model was considered poorly balanced if the standardised difference between pairs was \>10% of the standard deviation ([@bib0025]).

Analysis model {#sec0045}
--------------

Proportional hazard models were fitted, contrasting the time to event (acquisitive crime or DRP) between i*nitiators* and *non-initiators.* Subjects entered the risk set after the classification phase (i.e. two week's post-assessment). Multiple assessments belonging to the same individual were accounted for by adjusting the standard errors using the Huber-White sandwich estimator.

The same propensity score matched groups were used for the analyses of both outcomes. The matched sample was analysed by stratifying the Cox model on each matched group. *Non-initiators* were given weights equal to the inverse of the number of *non-initiators* in that matched group. For example, within a group with a matching ratio of 1:4 each *non-initiator* would be given ¼ weights and the *initiator* was given a weight of one. The Schoenfeld residuals were examined for departures from proportional hazards.

Missing data {#sec0050}
------------

Thirty percent (4480/14,802) of assessments in the analysis dataset had missing data for at least one of the baseline covariates used to calculate the propensity score. Initially those with missing data were excluded from the matched analysis. To account for potential selection bias in this approach, those with missing information were incorporated into the analysis using multiple imputation (ICE command, Stata 13) ([@bib0195]). Missing data distributions were calculated using all variables in Appendix A in Supplementary material, plus indicators for being an i*nitiator* and whether the subject had a death or an offence over follow-up. Ten imputed datasets were constructed and a propensity score model was fitted to each. The multiple imputation propensity score was taken as the mean of these and the matching process was repeated ([@bib0080]).

Sensitivity analysis {#sec0055}
--------------------

A planned sensitivity analysis was conducted to test the robustness of the results to one element of the study design: the definition of an *initiator*. This was performed by changing the length of the classification phase from two weeks to one week and then four weeks.

Results {#sec0060}
=======

There were 14,802 assessments identified for analysis and 12,948 person years of follow-up ([Table 1](#tbl0005){ref-type="table"}). Nine percent of assessments (1271) were classed as *initiators*.Table 1Summary of key statistics, initiators and non-initiators.Table 1StatisticInitiatorsNon-initiatorsN%[\*](#tblfn0005){ref-type="table-fn"}N%[\*](#tblfn0005){ref-type="table-fn"}Number of people1,25511,949 Person years1,10411,844 Assessments1,27113,531  Assessments with missing data for any variable304244,17631  Assessments in 1:5[\*\*](#tblfn0010){ref-type="table-fn"} matched sample908713,79028 Person years7803,247  Assessments in 1:5[\*\*](#tblfn0010){ref-type="table-fn"} matched sample after multiple imputation1,201945,04737 Person years1,0444,408[^1][^2]

Prior to matching, the standardised difference between *initiators* and *non-initiators* was small for many covariates ([Table 2](#tbl0010){ref-type="table"}). For example, *initiators* had a similar proportion of women and a similar mean age to *non-initiators*. There were differences with respect to the purpose of the baseline assessment: initiators were more likely to have been assessed as the result of a pre-sentence report, rather than a sentence review or start of their release on licence. *Initiators* were also more likely to be daily users of heroin and less likely to have declared alcohol use as a significant problem.Table 2Comparison between initiators and non-initiators on baseline covariates, classified within 8 groups, prior to and post propensity score matching.Table 2VariableInitiators N = 1271Non-initiators N = 13,531Standardised difference (%)N/mean%/±SDN/mean%/±SDAllMatchedGroup 1: demographic variablesGender Male9557510,42277−4.4−2.1 Female31625310923Mean age31.1±7.031.7±7.3−8.1−3.4Ethnicity White10848511,246834.6−0.8 Non-white106812849 Missing81610017Region Eastern87711198−5.40.0 East Midlands1851514651111.2−3.2 London85712469−9.32.8 North East70667752.35.1 North West264212676202.5−1.9 South East15412172813−2.01.4 South West84710318−3.9−0.5 West Midlands166131699131.51.0 Yorkshire& Humber17614189014−0.3−1.8  Group 2: relating to the assessmentPurpose of assessment Pre-sentence report4563626952036.2−1.1 Start community sent366293736282.64.8 Sentence review1199226417−22.00.0 Start licence13511236117−19.8−1.5 End sentence19515247518−7.9−3.3Sentence tied to the assessment Community5964752253915.4−2.0 Custody897155612−17.7−1.3 Suspended159131448114.7−4.1 Other198161993151.03.0 Community punishment1119164112−13.16.0Missing1189166812Mean assessment no.1.11±0.331.13±0.36−5.0−3.9Assessment financial year 2005--200635528421331−7.04.3 2006--200728723307323−0.3−0.5 2007--2008308243065233.7−1.3 2008--2009321253180244.1−2.5  Group 3: Offending which led to assessmentOffence which resulted in the probation assessment Violence/sexual103812739−4.70.0 Serious acquisitive21017244518−4.2−1.5 Non-serious acq.618495991448.6−1.1 Drugs offences15512174713−2.31.0 Other17614194514−1.62.2 Missing911301Are current offence(s) an escalation in seriousness from previous offending? Yes23418282321−6.50.0 No10077910,34276 Missing3023663Are current offence(s) an established pattern of similar offending?Yes10448210,840804.9−0.9No21717256019Missing1011311  Group 4: Drug use/problemsWas there evidence of motivation due to addictions/perceived needs? Yes887709055675.0−4.2 No36329413631 Missing2123403Did drugs act as a disinhibitor? Yes862688774655.8−6.5 No39531455334 Missing1412042Daily use of heroin? Yes10097997207217.71.9 No26221381128Currently injects heroin Yes516414896369.1−5.1 No75559863564Previously (but not currently) injected heroin Yes27922307623−1.9−0.3 No9927810,45577Other opiates or (non-prescribed) methadone Yes13611154311−2.20.0 No11358911,98889Crack use No765607627567.87.9 Occasionally133101286103.2−4.1 Frequently37329461834−10.3−5.8Previously used crack Yes350283338256.52.0 No9217210,19375Cocaine/amphetamine use Yes7168516−3.0−3.4 No12009412,68094Benzodiazepine use No11579112,42592−2.81.9 Occasionally40331625.0−1.3 Frequently7467906−0.1−1.3Other drug used? Yes6056925−1.8−4.3 No12119512,83995A current injector of a drug aside from heroin? Yes41032441233−0.7−3.7 No86168911967Violent behaviour related to drug use? Yes26321312923−6.1−6.3 No9987910,25876 Missing1011441Motivated to tackle drug misuse? Yes368293431258.12.7 Somewhat754597859582.6−1.6 No14511220116−14.1−1.3 Missing440Drug use and obtaining drugs a major activity/occupation? No14011172113−5.31.1 Somewhat470374795353.11.8 Significantly659526978520.4−2.4 Missing237Drug misuse issues linked to risk of serious harm, risks to the individual and other risks? Yes81464827461−6.2−5.1 No44535514438 Missing1211131Drug misuse issues linked to offending behaviour? Yes12139512,829953.7−4.7 No4946235 Missing91791  Group 5: AlcoholDid alcohol act as a disinhibitor? Yes17814233717−9.80.9 No10468210,53078 Missing4746645Is current alcohol use a problem? No9667696877210.10.5 Somewhat16613182914−1.4−1.6Significantly12810188614−12.01.1 Missing1111291Binge drinking or excessive use of alcohol in the last 6 months? Yes28022341525−7.72.4 No98077996874 Missing1111481Frequency and level of alcohol in the past No problems897719155686.1−1.5 Some problems12510153611−5.00.0 Significant problems23819269420−3.11.7 Missing1111461Motivated to tackle alcohol misuse? No problems10308110,449779.3−3.2 Some problems18815226017−5.42.2 Significant problems4136695−8.82.5 Missing1211531Alcohol misuse linked to offending behaviour Yes32626388429−7.33.5 No93574946770 Missing1011801  Group 6: Employment/housingUnstable accommodation Yes755597504557.70.9 No50640588243 Missing1011451Unemployed Yes11669212,287911.60.4 No94710528 Missing1111921In receipt of benefits? Yes10508310,891804.5−1.2 No19816232017 Missing2323202Financial issues linked to offending behaviour Yes10188010,594784.2−4.9 No24319280621 Missing1011311  Group 7: Mental/physical wellbeingCurrent psychiatric problems No problems10838511,216835.9−2.5 Some problems12410137110−1.3−0.4 Significant problems6359097−7.64.5 Missing135History of psychiatric treatment Yes1119137510−4.94.9 No11609112,15690Emotional wellbeing linked to offending behaviour Yes50340553741−2.9−2.9 No75459782358 Missing1411711Has physical or mental health conditions which need to be taken into account Yes52441577743−3.2−6.0 No72757750655 Missing2022482  Group 8: Offending history from PNC recordsMean years since last recorded offence0.35±0.690.45±0.68−15.7−3.3Mean previous acquisitive crimes \<4 weeks0.32±0.750.21±0.6317.24.5 4wks to 6 months1.21±1.711.06±1.688.91.4 6 months to 1 year0.89±1.590.90±1.54−0.8−2.1 Over one year20.7±22.021.6±21.2−3.9−7.8Previous non-acquisitive crimes \<4 weeks0.14±0.530.11±0.495.44.5 4 weeks to 6 months0.65±1.240.64±1.340.8−0.3 6 months to 1 year0.52±1.090.63±1.33−8.81.6 Over one year13.8±14.914.7±15.3−6.0−6.8Breach offences \<4 weeks0.17±0.490.18±0.52−2.10.0 \> 4weeks8.60±8.218.73±7.59−1.7−1.0

Overall there was good overlap of propensity scores between *initiators* and *non-initiators*, implying that there was good availability of potential matches ([Fig. 2](#fig0010){ref-type="fig"}). Following multiple imputation, to account for missing data, 95% of *initiators* (1201) and 37% of *non-initiators* (5047) were included in the analysis dataset.Fig. 2Distribution of propensity scores, averaged across 10 multiple imputation datasets, for initiator and non-initiator assessments where height indicates density of subjects.Fig. 2

After matching, all standardised differences were within the pre-specified 10% threshold, indicating that the propensity score matching approach was successful in achieving covariate balance between *initiators* and *non-initiators* ([Table 2](#tbl0010){ref-type="table"}). Therefore, further models which included interactions and higher order terms were judged unnecessary.

Drug-related poisoning risk initiators vs. non-initiators {#sec0065}
---------------------------------------------------------

There were 84 DRPs over follow-up, resulting in a mortality rate of 6.5 DRPs per 1000 person years (95% CI: 5.2--8.0). The rate of DRPs for *initiators* was less than half that for *non-initiators* ([Table 3](#tbl0015){ref-type="table"}). In the unmatched proportional hazard analysis, there was insufficient evidence to conclude a reduction in DRP following initiator-assessments (p = 0.12). In the matched analyses there was modest evidence of a reduction in DRP deaths (p = 0.06).Table 3Results of drug-related poisoning mortality analyses, comparing initiators and non-initiators: unmatched, propensity score matching and propensity score matching following multiple imputation (Number of assessments = 14,802).Table 3AnalysisGroupDeathsPerson yearsRate, per 1000 person year \[95% CI\]Hazard ratio \[95% CI\]p-valueUnmatchedInitiators311042.7 \[0.9, 8.4\]0.40 \[0.13, 1.26\]0.116Non-initiators8111,8446.8 \[5.5, 8.5\]Ref  1:5 matchedInitiators27802.6 \[0.6, 10.2\]0.30 \[0.09, 0.99\]0.048Non-initiators2532517.7 \[5.2, 11.4\]Ref  1:5 matched after MIInitiators310492.9 \[0.9, 8.9\]0.42 \[0.17, 1.04\]0.060Non-initiators3044136.8 \[4.8, 8.9\]Ref

Acquisitive offending risk initiators vs. non-initiators {#sec0070}
--------------------------------------------------------

The overall rate of recorded acquisitive offences was 0.91 per person year (95% CI: 0.86--0.96). The risk of an acquisitive offence was 22% higher following *initiator a*ssessments than following *non-initiator* assessments ([Table 4](#tbl0020){ref-type="table"}). In the matched analysis, the difference narrowed to 8%, and then 10% after multiple imputation.Table 4Results of acquisitive crime analyses, comparing initiators and non-initiators: unmatched, propensity score matching and propensity score matching following multiple imputation (No of assessments = 14,802).Table 4AnalysisGroupCrimesPerson yearsRate, per person year \[95% CI\]Hazard ratio \[95% CI\]p-valueUnmatchedInitiator5446660.82 \[0.75, 0.89\]1.22 \[1.11, 1.33\] \<0.001Non-initiators526179650.66 \[0.64, 0.68\]Ref  1:5 matchedInitiators3914640.84 \[0.76, 0.93\]1.08 \[0.99, 1.17\]0.102Non-initiators157920790.76 \[0.72, 0.80\]Ref  1:5 matched after MIInitiators5136360.81 \[0.74, 0.88\]1.10 \[1.02, 1.18\]0.015Non-initiators205228600.72 \[0.69, 0.75\]Ref

Sensitivity analyses {#sec0075}
--------------------

Changing the length of the classification phase from two weeks to one week or four weeks did not substantially change the estimates with respect to DRPs or acquisitive offences, although the p-values for the DRP analysis got larger (Appendix C in Supplementary material).

Discussion {#sec0080}
==========

There was a modestly significant reduction in DRP deaths associated with *being an initiator* that is consistent with the hypothesis that initial treatment contact is effective in reducing DRP deaths. However, the current study, in isolation, cannot establish this due to a lack of statistical power, as indicated by the wide confidence intervals. In contrast, the study found that, after adjusting for observed confounding, *initiators* had a ten percent higher offending rate, with lower 95% confidence interval close to neutrality. This result is at odds with the hypothesis that treatment contact is effective at reducing offending for offending-heroin users.

The study was designed to emulate elements of a controlled trial: using eligibility criteria; balancing groups at baseline; and analysing groups as treatment was initially planned, regardless of future treatment status. A large proportion of assessments were excluded from the analysis, mostly because, at the time of their assessment, the subject was already in treatment or they were incarcerated. These exclusion criteria were purposefully established, prior to analysis, to focus the study on the question: for heroin users identified from community probation, what is the effect of initiating contact with drug treatment services on future DRP mortality/acquisitive offending? Adopting eligibility criteria matches what occurs in randomised trials and has been recommended for wider use in observational research ([@bib0060], [@bib0075]).

Diagnostics showed that propensity score matching provided a cohort where the *initiator* and *non-initiator* assessments were balanced on observed covariates. However, we cannot rule out residual confounding because either: (i) there are further unobserved variables which explain group differences and are also related to outcome; or (ii) the covariates were poorly measured so that they failed sufficiently to capture the true difference.

Although an extensive set of covariates were available from probation assessments, in addition to historical offending information from police records, bias by unobserved confounding cannot be ruled out. The probation interview is specifically designed to assess future offending likelihood and has previously shown utility in this regard, ([@bib0100], [@bib0095]) however they might be less effective at identifying drug treatment need. Given that most covariates came from self-report, disclosure bias may mask true differences between groups. One study of the inter-rater reliability of probation interviews concluded that questions relating to drug use and accommodation had good reliability, whilst those relating to prior alcohol use and risk of serious harm had poor reliability ([@bib0135]). In England and Wales, when the cause of death is deemed to be unnatural then it is subject to a coroner inquest. Coding of the cause of death from a coroner's report is subject to error, and there may be some familial pressure to code the death as something other than drug-related, resulting in an underreporting of the number of DRPs.

One reason to believe that residual confounding exists is that there is no compelling theory to support an increase in offending following treatment contact, albeit the small one observed here. There is some confounding evident in the analysis: the estimated increase in offending, associated with being an initiator, changed from twenty to eight percent after propensity-score matching. The amount of unobserved confounding would have to be greater than that observed to change the inference towards a positive effect of treatment contact and given the number and range of variables used to calculate propensity scores, this seems unlikely. It should be noted that a recent UK-based randomised trial ([@bib0085]) found a similarly counter-intuitive result: supervised consumption of methadone over three months, compared to one-week supervision, resulted in an increase in offending (OR = 3.37, 95% CI: 1.3--8.9). In conjunction with this, our finding may warrant fresh investigation into the relationship between treatment and offending.

Utilising records from probation assessments allows subjects to be identified prior to entering treatment and provides an extensive set of variables to achieve balance. This approach has previously been used to assess the effect of alcohol treatment referral on recidivism --- a study that found no overall impact of the intervention ([@bib0125]). Alternative observational study designs compare treated and untreated periods. The DRP-risk reduction estimated here was consistent with that seen in such studies ([@bib0055]; [@bib0170]; [@bib0200]). In contrast to the findings presented here, studies of this type that investigate offending outcomes have tended to show lower rates in treatment than those observed out of treatment ([@bib0045]; [@bib0110]).

One difference between these studies and the current one is the different measures of treatment effectiveness. The object of the current analysis is to estimate the effect of *initial contact* with treatment, whilst other observational studies tend to estimate the effect of *receiving* treatment. The effect of initiating treatment is also likely to be more conservative because addiction-treatment tends to be most effective whilst subjects are being treated. To illustrate, in one Australian study of offending among prison leavers, comparing those who were on methadone maintenance at baseline with those who were not resulted in a Hazard ratio of 0.98 (95% CI: 0.88--1.09) and analysing according to being in treatment resulted in an HR of 0.80 (95% CI: 0.71--0.90) ([@bib0105]). One difficulty in measuring the effect of receiving treatment is that, because treatment exposure changes over follow-up, time-updated covariates are needed to account for confounding, but in most cases such variables will not be available. Even if sufficient data were collected, when treatment affects the future values of a time-dependent confounder standard estimation methods will still produce biased estimates ([@bib0175]). Regardless, the effect of initial treatment contact is of greater interest when assessing the effectiveness of current policy, as is the aim of the present analysis.

Another reason why our study might fail to reveal an effect of treatment on offending is because the cohort is restricted to those who were identified in the criminal justice system, with 63% of *initiators* have been referred to treatment from within the criminal justice system (compared to the national proportion of 26%) ([@bib0150]). The lack of evidence for criminal justice referral as a method of accessing treatment has been identified in a recent systematic review ([@bib0070]).

The results presented may be due to poor treatment adherence amongst those who started treatment and the negative effects of leaving treatment. It is noted that 6.4% of initiators (81/1271) did not receive any treatment following their triage appointment and we cannot expect treatment contact to be effective for these. A future analysis could use a similar design to investigate the effect of discontinuing treatment, selecting patients in long-term treatment and comparing those who discontinue treatment with those who do not. Irrespective of the lack of an effect on crime, it is striking that a very small proportion of those identified at a formal OASys assessment interview as regular heroin users, for whom treatment would appear to be indicated, subsequently went on to seek treatment.

The findings reported here raise questions concerning the referral of drug using offenders for treatment as a means to reduce crime, insofar as *initiation of contact* was not associated with a lower risk of offending among these CJS-involved participants. However, if the effect on DRP-deaths was established with further good-quality evidence, this could provide sufficient justification for continued investment, especially given the record-high number of DRP-deaths in the most recent statistics published in England and Wales ([@bib0155]). It has been previously noted that the criminal justice system has lagged behind medical research in adopting RCTs ([@bib0035]) and this ought to be addressed if we are to improve outcomes for offenders.
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[^1]: Percentage of all assessments.

[^2]: As the algorithm used to calculate the matched groups allowed initiator to have up-to (not exactly) five matches within the pre-specified calliper bounds the final ratio was not 1:5 (actual ratio 1:4.3).
